Efficacy of combination therapy with GABA, a DPP-4i and a PPI as an adjunct to insulin therapy in patients with type 1 diabetes

INTRODUCTION: The purpose of this retrospective clinic chart review study was to determine the potential of a combination therapy (CT) consisting of γ-aminobutyric acid (GABA), a dipeptidyl peptidase-4 inhibitor (DPP-4i), and a proton pump inhibitor (PPI) to improve glycemic control as an adjunct to...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabinovitch, Alexander, Koshelev, Daniil, Lagunas-Rangel, Francisco Alejandro, Kosheleva, Liudmila, Gavra, Tali, Schiöth, Helgi B., Levit, Shmuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246767/
https://www.ncbi.nlm.nih.gov/pubmed/37293502
http://dx.doi.org/10.3389/fendo.2023.1171886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246767/
https://www.ncbi.nlm.nih.gov/pubmed/37293502
http://dx.doi.org/10.3389/fendo.2023.1171886

Ejemplares similares